发明申请
- 专利标题： NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
- 专利标题（中）： 新化合物，药物组合物及其用途
-
申请号： US13489557申请日： 2012-06-06
-
公开(公告)号： US20130143892A1公开(公告)日： 2013-06-06
- 发明人: Armin HECKEL , Frank HIMMELSBACH , Elke LANGKOPF , Bernd NOSSE , Neil J. ASHWEEK , Nicole HARRIOTT
- 申请人： Armin HECKEL , Frank HIMMELSBACH , Elke LANGKOPF , Bernd NOSSE , Neil J. ASHWEEK , Nicole HARRIOTT
- 申请人地址： US CA San Diego DE Ingelheim am Rhein
- 专利权人： NEUROCRINE BIOSCIENCES, INC.,BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 当前专利权人： NEUROCRINE BIOSCIENCES, INC.,BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 当前专利权人地址： US CA San Diego DE Ingelheim am Rhein
- 优先权： EP11169297.6 20110609
- 主分类号： C07D413/14
- IPC分类号： C07D413/14 ; C07D403/12 ; C07D413/12 ; C07D403/14
摘要：
The present invention relates to compounds of general formula I, wherein R1, LP, HetAr, Ar, and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.
公开/授权文献
信息查询
